CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-07-05 | COZADD BRUCE C Chairman & CEO | Sale | −5,839 | $156.65 | $915K | 354,848 |
| 2022-07-05 | COZADD BRUCE C Chairman & CEO | Sale | −436 | $157.13 | $69K | 354,412 |
| 2022-07-05 | COZADD BRUCE C Chairman & CEO | Sale | −1,000 | $156.95 | $157K | 353,412 |
| 2022-07-05 | COZADD BRUCE C Chairman & CEO | Sale | −1,500 | $160.00 | $240K | 351,912 |
| 2022-07-05 | COZADD BRUCE C Chairman & CEO | Option exercise · Non-Qualified Stock Option (right to buy) | −9,700 | 9,632 | ||
| 2022-06-27 | Pearce Samantha SVP, Head of Europe & Internat | Option exercise | +8,508 | $109.45 | $931K | 19,817 |
| 2022-06-27 | Pearce Samantha SVP, Head of Europe & Internat | Sale | −8,508 | $155.00 | $1.3M | 11,309 |
| 2022-06-27 | Pearce Samantha SVP, Head of Europe & Internat | Option exercise · Non-Qualified Stock Option (right to buy) | −8,508 | 11,157 | ||
| 2022-06-08 | Pearce Samantha SVP, Head of Europe & Internat | Option exercise | +5,835 | $109.45 | $639K | 19,796 |
| 2022-06-08 | Pearce Samantha SVP, Head of Europe & Internat | Sale | −5,835 | $155.00 | $904K | 13,961 |
| 2022-06-08 | Pearce Samantha SVP, Head of Europe & Internat | Sale | −2,652 | $155.00 | $411K | 11,309 |
| 2022-06-08 | Pearce Samantha SVP, Head of Europe & Internat | Option exercise · Non-Qualified Stock Option (right to buy) | −5,835 | 19,665 | ||
| 2022-06-07 | Sablich Kim EVP & GM, North America | Sale | −200 | $148.21 | $30K | 26,995 |
| 2022-06-07 | Sablich Kim EVP & GM, North America | Sale | −250 | $149.22 | $37K | 26,745 |
| 2022-06-07 | Sablich Kim EVP & GM, North America | Sale | −573 | $150.68 | $86K | 26,172 |
| 2022-06-07 | Sablich Kim EVP & GM, North America | Sale | −1,317 | $151.87 | $200K | 24,855 |
| 2022-06-07 | Sablich Kim EVP & GM, North America | Sale | −101 | $152.60 | $15K | 24,754 |
| 2022-06-06 | Iannone Robert EVP, Global Head of R&D | Shares withheld for taxes | −1,295 | $149.25 | $193K | 38,109 |
| 2022-06-06 | Patil Neena M Chief Legal Officer (CLO) | Sale | −1,000 | $152.15 | $152K | 31,600 |
| 2022-06-06 | Sablich Kim EVP & GM, North America | Shares withheld for taxes | −1,759 | $149.25 | $263K | 28,583 |
Page 26 of 31 · 614 trades